Based on the results of the large-scale testing programme run in Luxembourg, researchers show that asymptomatic SARS-CoV-2 carriers represent an important vector for transmission.

Large-scale testing for SARS-CoV-2 has been a topic of intense political and societal debate, the rationale for screening asymptomatic individuals having been in particular questioned. Nevertheless, whether asymptomatic carriers play an important role in population-based transmission has remained an essential question. 

Luxembourg had been one of the first countries to implement a large-scale testing programme in May 2020, offering all of its residents and cross-border workers the opportunity to regularly and voluntarily get tested for free. The first phase of testing ran from 27 May until 15 September 2020 covered 49% of the resident and 22% of the cross-border worker populations, enabling the detection of 26% of all positive cases of the first epidemic wave.  This provided decision makers with evidence-based data and allowed to break infection chains early whereby the total number of cases would have been 43% higher without the testing over this period as shown by computer simulations. 

In addition, large-scale testing provides a unique test case for assessing the role of asymptomatic carriers. Based on the contact tracing data from phase 1 of the large-scale testing programme, Luxembourg researchers revealed that asymptomatic SARS-CoV-2 carriers are likely similarly infectious compared to symptomatic individuals.

About the large-scale testing

As part of its lockdown exit strategy, Luxembourg implemented an extensive and unique nation-wide testing campaign, inviting its residents and cross-border workers to voluntarily get tested for SARS-CoV-2. The aim of this large-scale testing (LST) initiative was to limit the spread of the SARS-CoV-2 virus by identifying positive cases early, including among asymptomatic individuals, thereby pre-emptively breaking infection chains. At the same time, LST contribute to the close monitoring of the spread of the virus among the Luxembourg population.

The first phase of the LST, coordinated by the Luxembourg Institute of Health (LIH) and supported by researchers at the University of Luxembourg, ran from 27 May until 15 September 2020 and relied on 16 ‘drive-through’ and 1 ‘walk-through’ test stations, with a maximum theoretical capacity of 20,000 tests per day. The population was divided into three main categories with different testing intervals. The first category was composed of people exposed to a high infectious risk by their professional activity (such as healthcare professionals) whereas the second category consisted of those having resumed their professional activity or were about to get back to work. The third category encompassed representative samples of the general population. The recurrent testing of the contingents and the rigorous contact tracing not only aimed at breaking nascent infection chains but also at providing decision makers with evidence-based data. Over the first phase of the LST, a total of 566,320 tests was performed based on a total of 1,436,000 invitations, which corresponds to 69,7% of all tests performed and an overall response rate of 39,4%.

➡️ Learn more on the large-scale testing